318 related articles for article (PubMed ID: 38708177)
1. Targeting Telomere Dynamics as an Effective Approach for the Development of Cancer Therapeutics.
Tao HY; Zhao CY; Wang Y; Sheng WJ; Zhen YS
Int J Nanomedicine; 2024; 19():3805-3825. PubMed ID: 38708177
[TBL] [Abstract][Full Text] [Related]
2. Potential Telomere-Related Pharmacological Targets.
Berei J; Eckburg A; Miliavski E; Anderson AD; Miller RJ; Dein J; Giuffre AM; Tang D; Deb S; Racherla KS; Patel M; Vela MS; Puri N
Curr Top Med Chem; 2020; 20(6):458-484. PubMed ID: 31916516
[TBL] [Abstract][Full Text] [Related]
3. Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies.
Jafri MA; Ansari SA; Alqahtani MH; Shay JW
Genome Med; 2016 Jun; 8(1):69. PubMed ID: 27323951
[TBL] [Abstract][Full Text] [Related]
4. Systematic Analysis of Compounds Specifically Targeting Telomeres and Telomerase for Clinical Implications in Cancer Therapy.
Lee HS; Carmena M; Liskovykh M; Peat E; Kim JH; Oshimura M; Masumoto H; Teulade-Fichou MP; Pommier Y; Earnshaw WC; Larionov V; Kouprina N
Cancer Res; 2018 Nov; 78(21):6282-6296. PubMed ID: 30166419
[TBL] [Abstract][Full Text] [Related]
5. Crossroads of telomere biology and anticancer drug discovery.
Seimiya H
Cancer Sci; 2020 Sep; 111(9):3089-3099. PubMed ID: 32579791
[TBL] [Abstract][Full Text] [Related]
6. [Telomere and telomerase as targets for anti-cancer drugs].
Ide T
Nihon Rinsho; 2004 Jul; 62(7):1271-6. PubMed ID: 15283143
[TBL] [Abstract][Full Text] [Related]
7. Prospects for anti-neoplastic therapies based on telomere biology.
Stewart SA; Hahn WC
Curr Cancer Drug Targets; 2002 Mar; 2(1):1-17. PubMed ID: 12188917
[TBL] [Abstract][Full Text] [Related]
8. Telomere maintenance as a target for drug discovery.
Sekaran V; Soares J; Jarstfer MB
J Med Chem; 2014 Feb; 57(3):521-38. PubMed ID: 24053596
[TBL] [Abstract][Full Text] [Related]
9. Anticancer therapy targeting telomeres and telomerase : current status.
Parkinson EK; Minty F
BioDrugs; 2007; 21(6):375-85. PubMed ID: 18020621
[TBL] [Abstract][Full Text] [Related]
10. Telomerase-based Cancer Therapeutics: A Review on their Clinical Trials.
Relitti N; Saraswati AP; Federico S; Khan T; Brindisi M; Zisterer D; Brogi S; Gemma S; Butini S; Campiani G
Curr Top Med Chem; 2020; 20(6):433-457. PubMed ID: 31894749
[TBL] [Abstract][Full Text] [Related]
11. [Inhibition of telomeres and telomerase. Seeking for new anticancer drugs].
Raymond E; Faivre S; Dieras V; Von Hoff D
Bull Cancer; 1997 Dec; 84(12):1123-33. PubMed ID: 9587365
[TBL] [Abstract][Full Text] [Related]
12. Agents that target telomerase and telomeres.
Raymond E; Sun D; Chen SF; Windle B; Von Hoff DD
Curr Opin Biotechnol; 1996 Dec; 7(6):583-91. PubMed ID: 8939642
[TBL] [Abstract][Full Text] [Related]
13. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects.
Kelland LR
Eur J Cancer; 2005 May; 41(7):971-9. PubMed ID: 15862745
[TBL] [Abstract][Full Text] [Related]
14. Telomere maintenance mechanisms as a target for drug development.
Bearss DJ; Hurley LH; Von Hoff DD
Oncogene; 2000 Dec; 19(56):6632-41. PubMed ID: 11426649
[TBL] [Abstract][Full Text] [Related]
15. Telomere uncapping by the G-quadruplex ligand RHPS4 inhibits clonogenic tumour cell growth in vitro and in vivo consistent with a cancer stem cell targeting mechanism.
Phatak P; Cookson JC; Dai F; Smith V; Gartenhaus RB; Stevens MF; Burger AM
Br J Cancer; 2007 Apr; 96(8):1223-33. PubMed ID: 17406367
[TBL] [Abstract][Full Text] [Related]
16. Telomeres and telomerase: Pharmacological targets for new anticancer strategies?
Pendino F; Tarkanyi I; Dudognon C; Hillion J; Lanotte M; Aradi J; Ségal-Bendirdjian E
Curr Cancer Drug Targets; 2006 Mar; 6(2):147-80. PubMed ID: 16529544
[TBL] [Abstract][Full Text] [Related]
17. Telomere Length Maintenance in Cancer: At the Crossroad between Telomerase and Alternative Lengthening of Telomeres (ALT).
De Vitis M; Berardinelli F; Sgura A
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29463031
[TBL] [Abstract][Full Text] [Related]
18. The role of telomerase and viruses interaction in cancer development, and telomerase-dependent therapeutic approaches.
Salimi-Jeda A; Badrzadeh F; Esghaei M; Abdoli A
Cancer Treat Res Commun; 2021; 27():100323. PubMed ID: 33530025
[TBL] [Abstract][Full Text] [Related]
19. [The role of alternative lengthening of telomeres mechanisms in carcinogenesis and prospects for using an anti-telomerase drugs in malignant tumors treatment].
Grach AA
Tsitologiia; 2011; 53(10):759-71. PubMed ID: 22232932
[TBL] [Abstract][Full Text] [Related]
20. Telomerase and its potential for therapeutic intervention.
Phatak P; Burger AM
Br J Pharmacol; 2007 Dec; 152(7):1003-11. PubMed ID: 17603541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
